Enzo Biochem (ENZ) Reports In-Line Q2 EPS

Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $24.2 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Cosmos Health posts 31% revenue gain in Q2 and H1 2026
• Benchmark Reiterates Buy Rating on Kyivstar Group (KYIV) Following Recent Rally